Orange Book product · Generic (ANDA)
TAZICEF
CEFTAZIDIME
At a glance
Mar 06, 1986
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 06, 1986
40 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
CEFTAZIDIME
Strength
1GM/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 062662
Product number
002
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CEFTAZIDIME
- 2011CEFTAZIDIME IN DEXTROSE CONTAINERBrand (NDA)
NDA 050823 · B BRAUN
- 1990CEPTAZBrand (NDA)
NDA 050646 · GLAXOSMITHKLINE
- 1985FORTAZBrand (NDA)
NDA 050578 · PAI HOLDINGS PHARM
- 2010CEFTAZIDIMEGeneric (ANDA)
ANDA 065481 · AUROBINDO PHARMA LTD
- 2010CEFTAZIDIMEGeneric (ANDA)
ANDA 065482 · AUROBINDO PHARMA LTD
- 2008CEFTAZIDIMEGeneric (ANDA)
ANDA 065196 · WOCKHARDT
- 1995PENTACEFGeneric (ANDA)
ANDA 063322 · GLAXOSMITHKLINE
- 1993TAZICEFGeneric (ANDA)
ANDA 064032 · HOSPIRA
- 1992PENTACEFGeneric (ANDA)
ANDA 064006 · GLAXOSMITHKLINE
- 1992PENTACEFGeneric (ANDA)
ANDA 064008 · GLAXOSMITHKLINE
- 1986TAZIDIME IN PLASTIC CONTAINERGeneric (ANDA)
ANDA 062739 · LILLY
- 1985CEFTAZIDIMEGeneric (ANDA)
ANDA 062640 · ACS DOBFAR
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
